Internal Reference Number: FOI_7863
Date Request Received: 04/04/2024 00:00:00
Date Request Replied To: 26/04/2024 00:00:00
This response was sent via: By Email
Request Summary: Haemophilia B and Von Willebrand Disease
Request Category: Researcher
| Question Number 1: Could you please provide answers to the following five questions related to the incidence and treatment of Haemophilia B and Von Willebrand Disease? Q1. How many patients has your Trust treated (for any medical condition) in the past 3 months with the following drugs: • Alphanate • Alprolix • BeneFIX • HaemateP • Idelvion • Refixia • Rixubis • Veyvondi • Voncento • Wilate • Willfact | |
| Answer To Question 1: • Alphanate 0 patients • Alprolix 0 patients • BeneFIX 0 patients • HaemateP 0 patients • Idelvion 0 patients • Refixia 0 patients • Rixubis 0 patients • Veyvondi 0 patients • Voncento <5 patients • Wilate 0 patients • Willfact 0 patients | |
| Question Number 2: How many patients have been treated in the past 3 months with: • Gene therapy for Haemophilia B ONLY • Desmopressin for Von Willebrand Disease ONLY • Tranexamic Acid for Von Willebrand Disease ONLY | |
| Answer To Question 2: • Gene therapy for Haemophilia B ONLY 0 Patients • Desmopressin for Von Willebrand Disease ONLY 0 Patients • Tranexamic Acid for Von Willebrand Disease ONLY <5 patients | |
| Question Number 3: Of the patients that were treated with Veyvondi in the past 3 months, how many patients received treatment: • During surgery • On demand to treat bleeding episodes | |
| Answer To Question 3: 0 patients received Veyvondi in the past three months. | |
| Question Number 4: Of the patients that were treated with Voncento in the past 3 months, how many patients received treatment: • During surgery • On demand to treat bleeding episodes | |
| Answer To Question 4: <5 Patients received Voncento during surgery <5 Patients received Voncentro during surgery, due to bleeding episodes. | |
| Question Number 5: How many patients are registered with your trust for the following diseases: • Haemophilia B • Von Willebrand Disease • Von Willebrand Disease - paediatric patients (age 17 or under) | |
| Answer To Question 5: • Haemophilia B 29 patients • Von Willebrand Disease 477 patients • Von Willebrand Disease - paediatric patients (age 17 or under) 15 patients. | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
